首页 文献索引 SCI期刊 AI助手
条件筛选
相关性 最新发表 最早发表
全文 标题 期刊 作者
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
模糊 精准
{{tag.shortname||tag.name}}:{{getFilterLabel(field)}} Clear All
Jose Alberto Navarro-Garcia,Joshua A Keefe,Jia Song et al. Jose Alberto Navarro-Garcia et al.
Chronic kidney disease (CKD) is a serious and progressive worldwide health problem affecting 15 % of the global population. CKD is associated to greater mortality rates due to secondary complications such as cardiovascular disease. Usual ca...
Kana N Miyata,Denise M Smith,Michifumi Yamashita et al. Kana N Miyata et al.
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) slow chronic kidney disease progression, but their renoprotective mechanisms in non-diabetic glomerular diseases remain unclear.
Laura Giordano,Sabbir Ahmed,Thomas K van der Made et al. Laura Giordano et al.
In chronic kidney disease (CKD), the progressive decline in renal function leads to the accumulation of endogenous metabolites in the bloodstream, exacerbating comorbidities.
Devinda S Muthusinghe,Pavani Senarathne,Kenta Shimizu et al. Devinda S Muthusinghe et al.
Background: In Sri Lanka, a high seroprevalence of antibodies against hantaviruses was reported in communities affected by chronic kidney disease of unknown etiology (CKDu). Recently, two rodent-borne hantaviruses, Lanka virus and Anjozorobe virus, were identified in these areas.
Anna Bußmann,Christian Speckemeier,Alexandra Ehm et al. Anna Bußmann et al.
As cardio-renal-metabolic diseases share predicting factors and given the social and economic importance of these diseases, approaches that address multiple relevant diseases such as type 2 diabetes mellitus, chronic kidney disease and cardiovascular disease can be of great interest, especially in time
Dahn Jeong,Stanley Wong,Mohammad Ehsanul Karim et al. Dahn Jeong et al.
Main outcomes and measures: Incidence of 5 groups of EHMs: chronic kidney disease and end-stage kidney disease (CKD and ESKD), type 2 diabetes (T2D), stroke, major adverse cardiac events (MACE), and neurocognitive disorders (NCD).
耗时 0.37786 秒,为您在 48206918 条记录里面共找到 10000 篇文章 [XML]